248 related articles for article (PubMed ID: 31323271)
1. Astragaloside IV protects against hyperglycemia-induced vascular endothelial dysfunction by inhibiting oxidative stress and Calpain-1 activation.
Nie Q; Zhu L; Zhang L; Leng B; Wang H
Life Sci; 2019 Sep; 232():116662. PubMed ID: 31323271
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway.
Leng B; Tang F; Lu M; Zhang Z; Wang H; Zhang Y
Life Sci; 2018 Sep; 209():111-121. PubMed ID: 30081006
[TBL] [Abstract][Full Text] [Related]
3. Improved Endothelium-Dependent Relaxation of Thoracic Aorta in Niclosamide-Treated Diabetic Rats.
Engin S; Yasar YK; Barut EN; Sezen SF
Cardiovasc Toxicol; 2021 Jul; 21(7):563-571. PubMed ID: 33772737
[TBL] [Abstract][Full Text] [Related]
4. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
Wang S; Peng Q; Zhang J; Liu L
Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with losartan and L-carnitine protects against endothelial dysfunction of streptozotocin-induced diabetic rats.
Sleem M; Taye A; El-Moselhy MA; Mangoura SA
Eur J Pharmacol; 2014 Dec; 744():10-7. PubMed ID: 25281836
[TBL] [Abstract][Full Text] [Related]
7. Protective Effect of Astragaloside IV on High Glucose-Induced Endothelial Dysfunction via Inhibition of P2X7R Dependent P38 MAPK Signaling Pathway.
Leng B; Li C; Sun Y; Zhao K; Zhang L; Lu ML; Wang HX
Oxid Med Cell Longev; 2020; 2020():5070415. PubMed ID: 33014270
[TBL] [Abstract][Full Text] [Related]
8. Dietary polyphenol morin rescues endothelial dysfunction in a diabetic mouse model by activating the Akt/eNOS pathway.
Taguchi K; Hida M; Hasegawa M; Matsumoto T; Kobayashi T
Mol Nutr Food Res; 2016 Mar; 60(3):580-8. PubMed ID: 26626705
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation.
Qiu LH; Xie XJ; Zhang BQ
Biol Pharm Bull; 2010; 33(4):641-6. PubMed ID: 20410599
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific vascular responses of the rat aorta: effects of moderate term (intermediate stage) streptozotocin-induced diabetes.
Han X; Shaligram S; Zhang R; Anderson L; Rahimian R
Can J Physiol Pharmacol; 2016 Apr; 94(4):408-15. PubMed ID: 26845285
[TBL] [Abstract][Full Text] [Related]
11. Lycopene attenuates endothelial dysfunction in streptozotocin-induced diabetic rats by reducing oxidative stress.
Zhu J; Wang CG; Xu YG
Pharm Biol; 2011 Nov; 49(11):1144-9. PubMed ID: 21517710
[TBL] [Abstract][Full Text] [Related]
12. Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats.
Serizawa K; Yogo K; Aizawa K; Tashiro Y; Ishizuka N
Cardiovasc Diabetol; 2011 Nov; 10():105. PubMed ID: 22107602
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg1 attenuates diabetic vascular endothelial dysfunction by inhibiting the calpain-1/ROS/PKC-β axis.
Lu M; Zhao F; Ran C; Xu Y; Zhang J; Wang H
Life Sci; 2023 Sep; 329():121972. PubMed ID: 37482213
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3,4-dihydroxyacetophenone on endothelial dysfunction in streptozotocin-induced rats with type 2 diabetes.
Liu C; Sun J; Xue F; Yi Y; Han A
J Cardiovasc Pharmacol; 2015 Jan; 65(1):22-7. PubMed ID: 25162436
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV Improves Vasodilatation Function by Regulating the PI3K/Akt/eNOS Signaling Pathway in Rat Aorta Endothelial Cells.
Lin XP; Cui HJ; Yang AL; Luo JK; Tang T
J Vasc Res; 2018; 55(3):169-176. PubMed ID: 29972829
[TBL] [Abstract][Full Text] [Related]
16. Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes.
Joshi A; Woodman OL
Naunyn Schmiedebergs Arch Pharmacol; 2012 Nov; 385(11):1083-94. PubMed ID: 22965470
[TBL] [Abstract][Full Text] [Related]
17. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress.
Qian LB; Wang HP; Chen Y; Chen FX; Ma YY; Bruce IC; Xia Q
Pharmacol Res; 2010 Apr; 61(4):281-7. PubMed ID: 19892019
[TBL] [Abstract][Full Text] [Related]
18. Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats.
Yin Y; Qi F; Song Z; Zhang B; Teng J
Biosci Trends; 2014 Aug; 8(4):217-26. PubMed ID: 25224628
[TBL] [Abstract][Full Text] [Related]
19. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
20. Jujuboside B Reduces Vascular Tension by Increasing Ca2+ Influx and Activating Endothelial Nitric Oxide Synthase.
Zhao Y; Zhang X; Li J; Bian Y; Sheng M; Liu B; Fu Z; Zhang Y; Yang B
PLoS One; 2016; 11(2):e0149386. PubMed ID: 26901291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
